Programmable RNA targeting with the single-protein CRISPR effector Cas7-11.

Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.

Single-cell Ribo-seq reveals cell cycle-dependent translational pausing.